Businesses can apply for a share of £4 million of capital investment available to enable research into antimicrobial resistance and advance the development of new products.
Programme: Innovate UK
Award: Up to £2m
Opens: 14th Sep 2016
Closes: 2nd Nov 2016
Innovate UK is looking to support organisations that can set out a clear vision of potential partnerships it will encourage with companies, universities and other research establishments. You should also detail the new antimicrobial resistance (AMR) projects you will undertake as a consequence of the capital investment.
You must have a clear plan for the translation and commercialisation of any research that the capital enables you to conduct. To maximise the impact of this investment, applicants should build on existing UK infrastructure and not recreate capabilities without justification.
Projects need to demonstrate that the capital investment grant they’re requesting will:
Examples of in-scope applications include:
Innovate UK realise that some aspects of the above may not come under capital and so organisations will need other sources of funding.
All applications must focus on reducing the impact of antibacterial resistance.